Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1747)	2/17/1999 11:20:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

Peter, Given how far off SEPR has been in predicting the time-frame in which Xopenex would be approved, I would tend to agree with you. From the moment they filed the NDA on they were continuously chanting "by the end of the year". Now here we are February of the next year and the line is "mid-year". If every drug ends up taking half a year longer to get approved than initially thought, '03 is gonna be here before ya know it! I still think its all due to unfair politics at the FDA. As happy as I am to be an investor in this company I don't think I would like to be in their business professionally --- too much political bullshit & other stuff that's out of your control.